Healthcare -
Biotechnology - NASDAQ - US
$ 4.465
-1.22 %
$ 399 M
Market Cap
-10.15
P/E
TRVI - TOTAL CURRENT LIABILITIES
Total Current Liabilities TRVI - Trevi Therapeutics, Inc.
5.82 M
LAST VALUE
-32.35%
2 YEAR CAGR
16.83%
5 YEAR CAGR
0.00%
10 YEAR CAGR